BRIDGEWAY CAPITAL MANAGEMENT, LLC - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 107 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2019$354,000
-59.5%
49,900
-72.3%
0.00%
-66.7%
Q4 2018$874,000
-33.9%
179,9000.0%0.01%
-7.7%
Q3 2018$1,322,000
+15.2%
179,9000.0%0.01%
+8.3%
Q2 2018$1,148,000
+17.3%
179,9000.0%0.01%
+9.1%
Q1 2018$979,000179,9000.01%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Casdin Capital, LLC 3,365,000$16,186,0001.49%
CADIAN CAPITAL MANAGEMENT, LP 5,517,767$26,540,0001.17%
NEEDHAM INVESTMENT MANAGEMENT LLC 1,590,000$7,646,0001.04%
Parkman Healthcare Partners LLC 420,000$2,020,0000.58%
Penn Capital Management Company, LLC 977,526$4,702,0000.49%
Bullseye Asset Management LLC 79,272$381,0000.37%
Bellevue Group AG 2,441,241$11,742,0000.19%
ESSEX INVESTMENT MANAGEMENT CO LLC 300,783$1,447,0000.18%
Granite Investment Partners, LLC 589,313$2,835,0000.13%
WRAPMANAGER INC 68,163$328,0000.10%
View complete list of GENMARK DIAGNOSTICS INC shareholders